Filing Details

Accession Number:
0000874015-21-000085
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-17 17:05:01
Reporting Period:
2021-06-15
Accepted Time:
2021-06-17 17:05:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874015 Ionis Pharmaceuticals Inc IONS Pharmaceutical Preparations (2834) 330336973
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1181560 T Frederick Muto 2855 Gazelle Court
Carlsbad CA 92010
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-15 5,000 $9.30 36,683 No 4 M Direct
Common Stock Disposition 2021-06-15 5,000 $36.50 31,683 No 4 S Direct
Common Stock Acquisiton 2021-06-15 5,000 $9.30 36,683 No 4 M Direct
Common Stock Disposition 2021-06-15 5,000 $36.55 31,683 No 4 S Direct
Common Stock Acquisiton 2021-06-15 5,000 $9.30 36,683 No 4 M Direct
Common Stock Disposition 2021-06-15 5,000 $36.85 31,683 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2021-06-15 5,000 $0.00 5,000 $9.30
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2021-06-15 5,000 $0.00 5,000 $9.30
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2021-06-15 5,000 $0.00 5,000 $9.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,000 2012-07-01 2021-06-30 No 4 M Direct
5,000 2012-07-01 2021-06-30 No 4 M Direct
0 2012-07-01 2021-06-30 No 4 M Direct
Footnotes
  1. Acquired as a result of exercising a stock option that was scheduled to expire on June 30, 2021. The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 18, 2020.
  2. Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 18, 2020.